Marshall Wace North America’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$7.61M Sell
60,934
-7,191
-11% -$897K 0.03% 407
2021
Q2
$8.54M Sell
68,125
-28,482
-29% -$3.57M 0.04% 404
2021
Q1
$13.1M Buy
96,607
+322
+0.3% +$43.8K 0.05% 341
2020
Q4
$8.75M Hold
96,285
0.04% 412
2020
Q3
$7.16M Buy
96,285
+1,195
+1% +$88.9K 0.05% 331
2020
Q2
$8.1M Buy
+95,090
New +$8.1M 0.05% 293